RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickson, Jr. as President RNA Disease Diagnostics Inc. New York, New York, UNITED STATES
BALTIMORE, June 01, 2021 (GLOBE NEWSWIRE) RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced today the appointment of John W. Erickson, Jr. to the newly created position of President. Mr. Erickson will lead day-to-day operations, reporting directly to RNADD’s co-founder and Executive Chairman, Allan Oberman.
In an executive management career spanning more than three decades, Mr. Erickson has worked with healthcare, life science and clinical diagnostics businesses ranging from venture capital backed start-ups to Fortune 50 companies, building out global commercial capabilities, leading marketing and sales teams, delivering operational excellence and profitable growth, whil